Logo image of HNRA

HNR ACQUISITION CORP (HNRA) Stock Fundamental Analysis

NYSEARCA:HNRA - NYSE Arca - US40472A1025 - Common Stock - Currency: USD

1.19  +0.08 (+7.21%)

After market: 1.32 +0.13 (+10.92%)

Fundamental Rating

1

HNRA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. HNRA may be in some trouble as it scores bad on both profitability and health. HNRA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HNRA has reported negative net income.
In the past year HNRA has reported a negative cash flow from operations.
HNRA Yearly Net Income VS EBIT VS OCF VS FCFHNRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -0.66%
ROE -0.79%
ROIC N/A
ROA(3y)-1.65%
ROA(5y)N/A
ROE(3y)-4.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNRA Yearly ROA, ROE, ROICHNRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -2 -4 -6 -8 -10

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HNRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNRA Yearly Profit, Operating, Gross MarginsHNRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, HNRA has about the same amount of shares outstanding.
HNRA has a better debt/assets ratio than last year.
HNRA Yearly Shares OutstandingHNRA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2M 4M 6M 8M 10M
HNRA Yearly Total Debt VS Total AssetsHNRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

HNRA has an Altman-Z score of 0.01. This is a bad value and indicates that HNRA is not financially healthy and even has some risk of bankruptcy.
HNRA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 0.01
ROIC/WACCN/A
WACCN/A
HNRA Yearly LT Debt VS Equity VS FCFHNRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 20M 40M 60M 80M

2.3 Liquidity

HNRA has a Current Ratio of 0.12. This is a bad value and indicates that HNRA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.12 indicates that HNRA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.12
HNRA Yearly Current Assets VS Current LiabilitesHNRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 200K 400K 600K 800K

More info and screens

1

3. Growth

3.1 Past

HNRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -5946.61%.
EPS 1Y (TTM)-5946.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, HNRA will show a very strong growth in Earnings Per Share. The EPS will grow by 115.22% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-126.86%
EPS Next 3Y160.73%
EPS Next 5Y115.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HNRA Yearly Revenue VS EstimatesHNRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 20M 40M 60M
HNRA Yearly EPS VS EstimatesHNRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HNRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HNRA Price Earnings VS Forward Price EarningsHNRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HNRA Per share dataHNRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

HNRA's earnings are expected to grow with 160.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-126.86%
EPS Next 3Y160.73%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HNRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HNR ACQUISITION CORP

NYSEARCA:HNRA (9/17/2024, 8:12:04 PM)

After market: 1.32 +0.13 (+10.92%)

1.19

+0.08 (+7.21%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-20 2024-08-20/bmo
Earnings (Next)N/A N/A
Inst Owners1.48%
Inst Owner Change0%
Ins Owners48.26%
Ins Owner Change0%
Market Cap6.59M
Analysts82.86
Price Target6.12 (414.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0
BVpS7.53
TBVpS7.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.66%
ROE -0.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.65%
ROA(5y)N/A
ROE(3y)-4.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.12
Altman-Z 0.01
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5946.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2Y-126.86%
EPS Next 3Y160.73%
EPS Next 5Y115.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12948%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y117.45%
EBIT Next 5Y92.69%
FCF growth 1Y-1419.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1419.41%
OCF growth 3YN/A
OCF growth 5YN/A